INNOEarnings•prnewswire•
Innocan Pharma Announces First Half Of 2025 Financial Results
Sentiment:Negative (30)
Summary
HERZLIYA, Israel and CALGARY, AB, Aug. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce its...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 27, 2025 by prnewswire